Gyneocology
ashraf khoramirad; mojtaba ansarishahidi; hasan rezaeijamaloei; parvaneh sadeghimoghadam
Volume 28, Issue 4 , September and October 2021, , Pages 509-520
Abstract
Introduction: Having an infant in the Neonatal Intensive Care Unit (NICU) is very stressful and increases the risk of postpartum depression. The aim of this study was to investigate the effect of mindfulness intervention on the prevention of postpartum depression in mothers with preterm infants admitted ...
Read More
Introduction: Having an infant in the Neonatal Intensive Care Unit (NICU) is very stressful and increases the risk of postpartum depression. The aim of this study was to investigate the effect of mindfulness intervention on the prevention of postpartum depression in mothers with preterm infants admitted to NICU. Materials and Methods: : In an interventional study, postpartum depression was compared in three groups under mindfulness-based developmental care (group 34 = 1), developmental care (group 39 = 2) and control (group 3 = 50). Sampling was purposive and group assignment was random. Data were collected using the Edinburgh Postpartum Depression Inventory and the Demographic Information Questionnaire. Results: The results of covariance analysis showed that the mean score of postpartum depression in the two months postpartum in the mindfulness-based developmental care group was significantly lower than the other two groups (pvalue <.01) While 78% of postpartum depression changes could be explained by the intervention R2 = 78%.. Conclusion: Mindfulness based interventions are effective in reducing postpartum depression scores and it is recommended that these interventions be considered at the NICUs for better effectiveness of developmental care programs and reduction of psychological complications in mothers.
Bi bi leila Hosseini; MohammadHasan Rakhshani; Esmat Vafaee Fard; Mitra Aldaghi; Nasrin Hashemian Nejad
Volume 20, Issue 5 , March and April 2014, , Pages 738-746
Abstract
Backgound: Neonatal respiratory distress is a main cause of preterm neonatal mortality. Surfactant is one of its standard treatments. The current study was conducted to compare clinical effects of different kinds of surfactant in the treatment of respiratory distress of preterm neonates admitted to NICU ...
Read More
Backgound: Neonatal respiratory distress is a main cause of preterm neonatal mortality. Surfactant is one of its standard treatments. The current study was conducted to compare clinical effects of different kinds of surfactant in the treatment of respiratory distress of preterm neonates admitted to NICU of Sabzevar.
Materials and Methods: This cross-sectional study was conducted on the preterm neonates admitted to NICU of Shahid Mobini Hospital of Sabzevar University of Medical Sciences, in 2009-2010. Sample size was 115 neonates at 95% confidence interval. Inclusion criteria were neonates with respiratory distress and 26-37 weeks gestional age who had been treated with surfactant. Exclusion criteria were neonates with 5-min Apgar score less than 7, neonates with major congenital anomalies, or neonates whose mothers received steroids before giving birth. The data were gathered by questionnaire to assess clinical effects of different kinds of surfactant in the treatment of preterm neonatal respiratory distress. The questionnaire was confirmed by content validity and inter-rater reliability (r=0.9). The data were analysed in SPSS software version 20 using descriptive statistics and non-parametric tests including ANOVA and multiple comparisons, kruskalwalis and chi-square.
Results: 41 neonates were allocated in a group with birth weight less than 1500 g and 74 neonates in a group equal or grater than 1500 g. According to the statistical tests, intubation duration in neonates less than 1500 g who received Newfactan was significantly more than the two other drugs (P=0.01). Duration of CPAP in Curosurf group was more than Survanta and Newfactan groups with a significant difference. Time of starting feeding was lesser in neonates who had recieved Survanta than Newfactan. In neonates less than 1500 g, none of the variables had a significant difference after surfactant therapy.
Conclusion: This study showed that Survanta has a better efficacy than Newfactan and Curosurf. But in regard to the importance of applying this drug, and the controversy of results obtained from studies, it is recommended to perform further studies about this issue.